Apellis Pharmaceuticals buy Saftman
Start price
17.03.23
/
50%
€57.93
Target price
17.03.24
-
Performance (%)
3.57%
End price
31.01.24
€60.00
Summary
This prediction ended on 31.01.24 with a price of €60.00. With a performance of 3.57%, the BUY prediction by Saftman for Apellis Pharmaceuticals closed with a slight gain. Saftman has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Apellis Pharmaceuticals | - | - | - |
| iShares Core DAX® | 4.015% | 2.971% | 16.492% |
| iShares Nasdaq 100 | 2.755% | 0.503% | 40.029% |
| iShares Nikkei 225® | -0.826% | -5.057% | 14.566% |
| iShares S&P 500 | 2.330% | 0.720% | 30.194% |
Comments by Saftman for this prediction
In the thread Apellis Pharmaceuticals diskutieren
Saftman hat das Wertpapier Apellis Pharmaceuticals in seinem Wikifolio Langfristige Aufwärtstrends gekauft.